Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 145

    USFDA bans sale of Transvaginal Surgical Mesh citing safety concerns

    USFDA bans sale of Transvaginal Surgical Mesh citing safety concerns

    Farhat Nasim17 April 2019 9:50 AM IST
    Transvaginal Surgical Mesh, made of synthetic or biological material, are commonly implanted in women to repair weakened or damaged tissue and provide...
    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

    Farhat Nasim17 April 2019 9:45 AM IST
    Zydus Cadila Group Chairman Pankaj R Patel said this innovation has the potential to bring about a paradigm shift in the management of CKD patients...
    Cancer drugs Darzalex, Imbruvica drive JnJ to better than expected quarterly profit

    Cancer drugs Darzalex, Imbruvica drive JnJ to better than expected quarterly profit

    Garima17 April 2019 9:40 AM IST
    JnJ, the first major drugmaker to report first-quarter results, reported a slight rise in quarterly sales to $20.02 billion, above the average...
    Recordati to seek Canadian approval for kidney disease drug Cystagon

    Recordati to seek Canadian approval for kidney disease drug Cystagon

    Medical Dialogues Bureau17 April 2019 9:08 AM IST
    In 2017, Horizon won Health Canada's approval for Procysbi, making it much harder for Canadian patients to access Cystagon.TORONTO: Italy's Recordati...
    Roche ups outlook as sales growth offsets price hit

    Roche ups outlook as sales growth offsets price hit

    Garima17 April 2019 9:00 AM IST
    Drugs division chief Bill Anderson said Roche Pharmaceutical's drug revenue is soaring even as it honours a price-freeze pledge it made last year...
    Lupin gets USFDA nod to generic version of Prozac tablets

    Lupin gets USFDA nod to generic version of Prozac tablets

    Farhat Nasim16 April 2019 9:45 AM IST
    The company has received approval from the US Food and Drug Administration(USFDA) to market its product which is a generic version of Eli Lilly and...
    Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

    Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

    Garima16 April 2019 9:40 AM IST
    Pulmazole an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
    Gelesis gets USFDA nod to weight-loss hydrogel pill PLENITY

    Gelesis gets USFDA nod to weight-loss hydrogel pill PLENITY

    Farhat Nasim16 April 2019 9:32 AM IST
    BOSTON: Gelesis, a biotechnology company developing first-in-class hydrogel therapeutics to treat obesity and other chronic diseases related to the...
    Wockhardt gets zero USFDA observations for Bioequivalence centre

    Wockhardt gets zero USFDA observations for Bioequivalence centre

    Medical Dialogues Bureau16 April 2019 9:31 AM IST
    Bioequivalence studies of Tamsulosin 0.4mg capsules and Metoprolol Tartrate 200mg ER tablets were audited, Wockhardt had reported.New Delhi: Shares of...
    Amgen sets over Rs 15 lakh yearly price for new bone drug Evenity

    Amgen sets over Rs 15 lakh yearly price for new bone drug Evenity

    Medical Dialogues Bureau16 April 2019 9:30 AM IST
    The U.S. Food and Drug Administration last week approved Amgen Inc's bone-building Evenity for postmenopausal women who are at high risk of fracture...
    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Farhat Nasim15 April 2019 10:05 AM IST
    Bimatoprost Ophthalmic Solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...
    Dr Reddy

    Dr Reddy's expands injectable portfolio with acquisition of 42 ANDAs in US

    Farhat Nasim15 April 2019 10:00 AM IST
    This transaction will help augment Dr Reddy's Labs injectables product portfolio in the U.S. market and globally.Hyderabad: Dr Reddy's Laboratories...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Health Insurance- The Best Backup Plan in Today

    Health Insurance- The Best Backup Plan in Today's Times

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok